Advertisement

Topics

Certara Supports the Not-for-profit Biotechnology Company Medicines Development for Global Health (MDGH) on the FDA New Drug Approval of Moxidectin for the Treatment of River Blindness (Onchocerciasis), a Neglected Tropical Disease

08:00 EDT 14 Jun 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Certara was privileged to participate as a key member of the Medicines Development for Global Health development team to achieve FDA approval of moxidectin Certara®, the global leader in model-informed drug development, ...

Other Sources for this Article

Certara Contact:
Ellen Leinfuss, 609-216-9586
Chief Commercial Officer
or
Media Contact:
Rana Healthcare Solutions
Lisa Osborne, 206-992-5245
lisa@ranahealth.com

NEXT ARTICLE

More From BioPortfolio on "Certara Supports the Not-for-profit Biotechnology Company Medicines Development for Global Health (MDGH) on the FDA New Drug Approval of Moxidectin for the Treatment of River Blindness (Onchocerciasis), a Neglected Tropical Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...